Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | PDGFRB | P09619 | 17/20 | 0.54 |
| ▸ | PDGFRA | P16234 | 17/20 | 0.54 |
| ▸ | NQO2 | P16083 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | INSR | P06213 | 1/20 | 0.49 |
| ▸ | LCK | P06239 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13008677 | 0.91 | PDGFRB (0.48) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL14437926 | 0.90 | PDGFRB (0.46) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL14437925 | 0.90 | PDGFRB (0.46) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL24140225 | 0.82 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL14437924 | 0.79 | PDGFRB (0.63) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL29639032 | 0.78 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2GAAMAPTPDGFRB | |
| SCHEMBL2679771 | 0.78 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2GAAMAPTPDGFRB | |
| SCHEMBL23171118 | 0.78 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL9730991 | 0.78 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2GLAGAAMAPT | |
| SCHEMBL23352099 | 0.78 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2GLAGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118059-B2 | Film, film forming method, optical filter, laminate, solid image pickup element, image display device, and infrared sensor | FUJIFILM CORPORATION (JP) | 2021-09-14 | — | — | US | disclosed |
| US-10947389-B2 | Composition, film, near infrared cut filter, laminate, pattern forming method, solid image pickup element, image display device, infrared sensor, and color filter | FUJIFILM CORPORATION (JP) | 2021-03-16 | — | — | US | disclosed |
| EP-3301448-B1 | METHYLGLYOXAL AS A MARKER OF CANCER | ASSOCIATION POUR LA RECH THERAPEUTIQUE ANTI CANCEREUSE (FR) | 2021-03-03 | — | — | EP | disclosed |
| EP-3301448-A1 | METHYLGLYOXAL AS A MARKER OF CANCER | Association pour la Recherche Thérapeutique Anti-Cancéreuse (FR) | 2018-04-04 | — | — | EP | disclosed |
| CN-104854458-B | Methylglyoxal as a marker for cancer | 抗癌治疗研究协会 | 2018-02-09 | — | — | CN | disclosed |
| EP-2912465-B1 | METHYLGLYOXAL AS A MARKER OF CANCER | ASS POUR LA RECH THÉRAPEUTIQUE ANTI-CANCÉREUSE (FR) | 2017-10-25 | — | — | EP | disclosed |
| US-20160178637-A1 | DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES | THE UNIVERSITY OF WARWICK (GB) | 2016-06-23 | — | — | US | disclosed |
| EP-3030904-A1 | DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES | The University Of Warwick (GB) | 2016-06-15 | — | — | EP | disclosed |
| US-20150301056-A1 | METHYLGLYOXAL AS A MARKER OF CANCER | ASSOCIATION POUR LA RECHERCHE THERAPEUTIQUE ANTI-CANCEREUSE (FR) | 2015-10-22 | — | — | US | disclosed |
| EP-2912465-A1 | METHYLGLYOXAL AS A MARKER OF CANCER | Association pour la Recherche Thérapeutique Anti-Cancéreuse (FR) | 2015-09-02 | — | — | EP | disclosed |
| CN-1280572-A | Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase | RHONE POULENC RORER PHARMA (US) | 2001-01-17 | — | — | CN | disclosed |
| EP-1001945-A4 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES | RHONE POULENC RORER PHARMA (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-1001946-A4 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES | RHONE POULENC RORER PHARMA (US) | 2000-07-26 | — | — | EP | disclosed |
| CN-1261353-A | Inhibition of platelet-derived growth factor and/or p56lckQuinoline and quinoxaline compounds of tyrosine kinases | RHONE POULENC RORER PHARMA (US) | 2000-07-26 | — | — | CN | disclosed |
| WO-2000031051-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS AS PDGF-RECEPTOR AND/OR LCK TYROSINE KINASE INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000031049-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS AS PDGF-R AND/OR LCK TYROSINE KINASE INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| EP-1001946-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-05-24 | — | — | EP | disclosed |
| EP-1001945-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1998054158-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| WO-1998054157-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |